Abstract Details

Title Flipped classroom in neurology: principles, practices, and perspectives

Topic Research Methodology, �鶹��ýӳ��, and History

Presentation(s) P7 - Poster Session 7 (5:30 PM-6:30 PM)

Poster/Presentation
Number 13-012

Objective To critically review current deployment of flipped classrooms in neurology education.

Background How to most effectively deliver a large amount of information in an engaging environment that encourages critical thinking is a question that has long plagued educators. The ‘flipped classroom’ approach is taking the center stage within medical education, but an extensive review of current practices in neurology is still lacking.

Design/Methods A team of educators from the �鶹��ýӳ��’s A. B. Baker Section on Neurological �鶹��ýӳ�� reviewed the current evidence regarding the implementation of the flipped classroom format.

Results While generally, but not always, learners enjoy the preparatory materials, self-directed pace, and personalization of the flipped classroom, a number of obstacles to its implementation exist, most notably learner time commitments. Flipped classrooms may be more effective in areas in which there is a lack of uniformity of expertise in a certain subspecialty, such as sleep medicine, as this allows learners to acquire foundational knowledge at their own pace and reinforces its application during in-classroom experiences. While the ideal formats and evaluation strategies are yet to be delineated, a mix of traditional lectures and modern adult-learning-based education might prove to be optimal. Given the large temporal and financial commitments involved in flipping the neurological classroom, it is pivotal to gauge their effectiveness before broad application.

Conclusions A modest evidence-base exists detailing the quantitative and qualitative implementation of flipped classrooms in neurology education. Nonetheless, the reported successes and limitations highlight that universal application of flipped classrooms is impractical. As such, we have identified areas within curricula that may be amenable to modern andragogical formats, as those in limited subspecialty areas or with some degree of pre-existing foundational knowledge among the learners. Finally, any new curriculum should account for and assess the impact on primary stakeholders.

Authors/Disclosures
Stefano Sandrone, PhD PRESENTER	Dr. Sandrone has nothing to disclose.
Jimmy V. Berthaud, MD (Methodist Healthcare)	Dr. Berthaud has nothing to disclose.
Chad Carlson, MD, F�鶹��ýӳ�� (Froedtert & Medical College of Wisconsin)	Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Jacquelyne Kane, MD (Evicore healthcare)	No disclosure on file
Neel Dixit, MD (VCU)	Dr. Dixit has nothing to disclose.
Amtul Farheen, MD, F�鶹��ýӳ�� (Jackson VA Medical Center)	Dr. Farheen has nothing to disclose.
Jessica B. Kraker, MD, F�鶹��ýӳ�� (Tulane University School of Medicine)	Dr. Kraker has or had stock in Doximity. An immediate family member of Dr. Kraker has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Kraker has received personal compensation in the range of $5,000-$9,999 for serving as a Peer instructor on surgical robot with Globus Medical.
James W. Owens, Jr., MD, PhD (University of Iowa Stead Family Department of Pediatrics)	Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Speare Law Firm. Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as a Question Writer with �鶹��ýӳ��.
Gustavo A. Patino, MD, PhD (Western Michigan University Homer Stryker MD School of Medicine)	Dr. Patino has nothing to disclose.
Harini Sarva, MD, F�鶹��ýӳ�� (Weill Cornell Medical Center)	Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Daniel Weber, DO (St. Louis University)	Dr. Weber has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Logan D. Schneider, MD (Stanford/VA Alzheimer's Center)	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.